In contrast, anti-IL-10 monoclonal antibody treatment in Py+Sp co-infected mice was sufficient to significantly reduce the severity of Pneumococcal infection compared to control IgG treated Py+Sp mice (Figure 4D). The gene discussed is IL10; the disease is pneumococcal infection.